Erratum to: Safety and Immunogenicity of an AS01-adjuvanted Varicella-zoster Virus Subunit Candidate Vaccine Against Herpes Zoster in Adults ≥50 Years of Age.

Autor: Chlibek R; Department of Epidemiology, Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Czech Republic., Bayas JM; Centro de Vacunación de Adultos, Servicio de Medicina Preventiva y Epidemiología, Hospital Clínic, Barcelona, Spain., Collins H; Anderson & Collins Clinical Research, Inc, Edison, New Jersey., de la Pinta MLR; Occupational Risk Prevention Department, Puerta de Hierro Hospital, Madrid, Spain., Ledent E; GlaxoSmithKline Vaccines, Rixensart, Belgium., Mols JF; GlaxoSmithKline Vaccines, Rixensart, Belgium., Heineman TC; GlaxoSmithKline Vaccines, King of Prussia, Pennsylvania.
Jazyk: angličtina
Zdroj: The Journal of infectious diseases [J Infect Dis] 2021 Feb 03; Vol. 223 (2), pp. 353.
DOI: 10.1093/infdis/jiaa560
Databáze: MEDLINE